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month-old PHT. This study showed that the early develop-
ment of vascular dysfunction in the endothelial cells as well
as vascular smooth muscle cells in PHT rabbits. These results
suggest that post-prandial hypertriglyceridemia may become
an important risk factor for promoting atherosclerosis.
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Losartan ameliorates diabetic vascular hyper-reactivity to
angiotensin II by reducing ROCK1 expression and activity
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Alessandro Mugelli, Paola Failli. Department of Pharmacology,
University of Florence, Italy
We investigated the effect of an in vivo treatment with
losartan, an angiotensin type 1 receptor antagonist (ARB), on
the angiotensin II (ATII) contracture elicited in phenylephrine
pre-contracted aortic strips isolated from normo (groups A
and B) and hyperglycemic rats (STZ injected, 55 mg/kg;
group C and D) not treated (groups A and C) and treated
with losartan (20 mg kg−1 day−1; groups B and D). While
ATII showed similar E50 values in all the preparations
tested, its maximum effect (expressed as % of maximum
phenylephrine contraction) reached 360% in group C, 250%
in group D and only 175% in groups A and B. Aortas from
all the animal groups responded similarly to irbesartan, an
ARB, added to superfusion medium (50% reduction of the
ATII maximum effect). The ATII contracture in groups C
and D were reduced (32% and 22% respectively) by fasudil,
an inhibitor of the RhoA/ROCK1 pathway. Exposure to the
same drug left unchanged the ATII contracture in the aortas
from groups A and B. ROCK1 enzyme activity (mU/mg of
tissue proteins) was 0.04±0.01 in normoglycemic, 1.42±
0.22* (p<0.001 vs. groups A and B) in diabetic aortas and
only 0.72±0.05§ (§p<0.05 vs. groups A and B) in the
aortas from losartan-treated diabetic rats.
In diabetes, ROCK1 overexpression is functionally coupled
with aorta hyper-reactivity towards ATII. We provide evidence
stating that losartan ameliorates vascular response to ATII
reducing ROCK1 activity and expression.
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Synthetic flavonol preserves postischemic endothelial
function after 7 days reperfusion in conscious sheep
Sheng Wang, Colleen J. Thomas, Greg J. Dusting, Owen L.
Woodman, Clive N. May. Howard Florey Institute and
Melbourne University, Australia
Myocardial ischemia–reperfusion impairs endothelium-de-
pendent dilatation due to oxidative stress. The synthetic
flavonol, 3′,4′-dihydroxyflavonol (DiOHF), is an effective
antioxidant which reduces infarct size. This study in
conscious, instrumented sheep subjected to experimental
myocardial infarction investigated the ability of DiOHF to
preserve post-ischemic coronary endothelial function. Acet-
ylcholine (ACh, 10 μg/kg/min iv) increased coronary
conductance (CC) before ischemia (ΔCC, ACh, 34±4%). In
vehicle-treated sheep (n=4) following prolonged (1 h)
ischemia and 24 h reperfusion, vasodilatation of the coronary
vascular bed to ACh was significantly reduced (ΔCC, 7±
2%). p<0.05). This impairment of endothelial function
persisted even after 7 days of reperfusion (ΔCC 15±2%).
In DiOHF-treated sheep (2 mg/kg i.v. bolus 5 min before
reperfusion, n=4), however, coronary vasodilatation in
response to acetylcholine was partly preserved after 24 h of
reperfusion (ΔCC 18±5% n.s.) and completely recovered
(ΔCC 31±7% n.s.) after 7 days of reperfusion. Animals in
both groups maintained vascular responses to SNP during
reperfusion, confirming normal function of vascular smooth
muscle. DiOHF also significantly decreased infarct size
expressed as a percentage of area at risk by approximately
40% (vehicle=80±7%, DiOHF=46±11%). In conclusion,
this study provides functional evidence that DiOHF protects
against endothelial dysfunction caused by ischemia and
reperfusion.
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Endothelium-dependent prothrombotic and fibrinolytic
factors in patients with chronic heart failure
K.A. Khmelnitskaya, E.V. Shlyakhto, M.U. Sitnikova. Pavlov
State Medical University, Almazov Research Institute of
Cardiology, Saint-Petersburg, Russia
Along with disturbance of blood flow, a hypercoagulable
state, endothelium plays an important regulatory role throm-
boembolic pathophysiology and produces prothrombotic and
antithrombotic factors in the chronic heart failure (CHF). In study
we have investigated endothelial-dependent hemostasis [von
Willebrand factor (vWf), tissue plasminogen activator (tPA)] and
endothelial damage [circulating endothelial cells (CECs), an
index of endothelial damage] in 108 patients with ischemic heart
disease and CHF I–IV class (NYHA), who were compared with
30 age-matched patients with ischemic heart disease without
CHF and 27 age-matched healthy control subjects.
Results: There was an increase plasma levels CECs in pa-
tients with CHF compared without CHF (p=0.002) and healthy
controls (p=0.001). Patients with more severe symptoms CHF
(class III–IV) had higher CECs (p=0.01), vWf (p=0.02), lower
tPA-antigen (p=0.1), than class I–II. A significant increase
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